AtheroNova Inc. announced that Erik SG Stroes, MD, Chair and Professor at the Department of Vascular Medicine at the Academic Medical Center (AMC), Amsterdam has joined the company as a member of the Clinical Advisory Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -26.67% |
2016 | AtheroNova Operations, Inc. Bankruptcy Case Dismissed | CI |
2015 | First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-26.67% | 9.69K | |
+32.76% | 50.85B | |
+0.10% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.45% | 26.11B | |
-22.11% | 19.13B | |
+8.48% | 13.05B | |
+27.25% | 12.16B | |
+24.77% | 12.08B |
- Stock Market
- Equities
- AHROQ Stock
- News AtheroNova Inc.
- AtheroNova Inc. Appoints Dr. Erik Stroes to its Clinical Advisory Board